Part 3/9:
While industry moves garner attention, academic research offers concrete proof of AI's capabilities. Massachusetts Institute of Technology (MIT) conducted a study where generative AI models designed a staggering 36 million molecular compounds. From this enormous pool, researchers identified two novel antibiotics that had never before been discovered.
These antibiotics were subsequently lab-tested on mice, successfully killing bacteria. This isn't just a theoretical breakthrough—it's a tangible step forward in combating drug-resistant bacteria like MRSA and gonorrhea, which have become increasingly resilient to traditional antibiotics.